Skip to main content
Log in

Expression of metallothionein in initial and relapsed childhood acute lymphoblastic leukemia

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

In a retrospective study we analzyed the expression of metallothionein (MT) in initial acute lymphoblastic leukemia (ALL) of 92 children and in relapsed ALL of 27 children using immunohistochemistry. MT expression was detectable in 33% of the patients with initial ALL and in 33% of the patients with relapsed ALL. No differences were seen concerning the intensity and the proportion of positively stained cells between initial and relapsed patients. The expression of MT was independent of clinical prognostic factors such as age, sex, immunological subtype, and initial blast cell count. Patients with initial ALL and MT expression tended to have a lower probability of disease-free survival compared with the MT-negative group. The relapsed patients with MT expression showed also a trend toward a shorter survival in comparison to the MT-negative group. However, the differences were not statistically significant. Thus, the results show that MT expression is not an important prognostic factor in the clinical drug resistance of childhood All.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Angel P, Karin M (1991) The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta 1072:129–157

    PubMed  Google Scholar 

  2. Bennet JM, Catowsky D, Daniel MT, Flandrin G, Galton GAR, Gralnick HR, Sultan C (1976) Proposal for the classification of the acute leukemias. French American British (FAB) cooperative group. Br J Haematol 33:451–458

    PubMed  Google Scholar 

  3. Black SM, Wolf CR (1991) The role of glutathione-dependent enzymes in drug resistance. Pharmacol Ther 51:139–154

    PubMed  Google Scholar 

  4. Chin JL, Banerjee D, Kadhim SA, Kontozoglou TE, Chauvin PJ, Cherian MG (1993) Metallothionein in testicular germ cell tumors and drug resistance. Cancer 72:3029–3035

    PubMed  Google Scholar 

  5. Cox DR (1972) Regression models and life tables. J R Stat Soc (B) 34:187–220

    Google Scholar 

  6. Danielson KG, Ohi S, Huang PC (1982) Immunochemical detection of metallothionein in specific epithelial cells of rat organs. Proc Natl Acad Sci USA 79:2301–2304

    PubMed  Google Scholar 

  7. Endicott JA, Ling V (1989) The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58:137–171

    PubMed  Google Scholar 

  8. Efferth T, Mattern J, Volm M (1992) Immunohistochemical detection of P-glycoprotein, glutathione-S-transferase and DNA topoisomerase II in human tumors. Oncology 49:368–375

    PubMed  Google Scholar 

  9. Farnworth P, Hillcott B, Ross I (1990) Metallothionein like proteins and cell resistance to cis-dichlorodiamminplatinum (II) in L1210 cells. Cancer Chemother Pharmacol 25:411–417

    PubMed  Google Scholar 

  10. Goasguen JE, Dissot JM, Fardel O, Lemee F, Legall E, Lebeay R, Leprise PY, Chaberon J, Fauchet R (1993) Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implication. Blood 81:2394–2398

    PubMed  Google Scholar 

  11. Hamer DH (1986) Metallothionein. Annu Rev Biochem 55:913–951

    PubMed  Google Scholar 

  12. Kaplan EL, Meier P (1956) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481

    Google Scholar 

  13. Kasahara K, Fujiwara Y, Nishio K, Ohmori T, Sugimoto Y, Komiya K, Matsuda T, Saijo N (1991) Metallothionein content correlates with sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res 51:3237–3242

    PubMed  Google Scholar 

  14. Kelly SL, Basu A, Teicher BA, Hacker MP, Hamer DH, Lazo JS (1988) Overexpression of metallothionein confers resistance to anticancer drugs. Science 241:1813–1815

    PubMed  Google Scholar 

  15. Kontozoglou TE, Banerjee D, Cherian MG (1989) Immuno-histochemical localization of metallothionein in human testicular embryonal carcinoma cells. Virchows Archiv [A] 415:545–549

    Google Scholar 

  16. Mattern J, Volm M (1992) Increased resistance to doxorubicin in human non-small cell lung carcinomas with metallothionein expression. Int J Oncol 1:687–689

    Google Scholar 

  17. Pieters R, Hongo T, Loonen AH, Huisman DR, Broxterman HJ, Hählen K, Veerman AJP (1992) Different types of non-P-glycoprotein-mediated multiple drug resistance in children with relapsed acute lymphoblastic leukemia. Br J Cancer 65:691–697

    PubMed  Google Scholar 

  18. Sauerbrey A, Zintl F, Volm M (1994) P-glycoprotein and glutathione S-transferase-π in childhood acute lymphoblastic leukemia. Br J Cancer (in press)

  19. Schilder RJ, Hall L, Monks A, Handel LM, Fornace AJ, Ozols RF, Fojo AT, Hamilton TC (1990) Metallothionein gene expression and resistance to cisplatin in human ovarian cancers. Int J Cancer 45:416–422

    PubMed  Google Scholar 

  20. Ubezio P, Limonta M, D'Lncalci M, Damia G, Masera G, Guidici G, Wolferton JS, Beck WT (1989) Failure to detect the P-glycoprotein multidrug resistant phenotype in cases of resistant childhood acute lymphoblastic leukemia. Eur J Cancer Clin Oncol 25:1895–1897

    PubMed  Google Scholar 

  21. Volm M, Bak M, Efferth T, Lathan B, Mattern J (1988) Immunocytochemical detection of resistance-associated glycoprotein in tissue culture cells, ascites tumors and human xenografts by Mab 265/F4. Anticancer Res 8:531–536

    PubMed  Google Scholar 

  22. Volm M, Mattern J (1992) Expression of topoisomerase II, catalase, metallothionein and thymidylate-synthase in human squamous cell lung carcinomas and their correlation with doxorubicin resistance and with patients' smoking habits. Carcinogenesis 3:1947–1950

    Google Scholar 

  23. Volm M, Mattern J (1993) Detection of multiple resistance mechanisms in untreated human lung cancer. Onkologie 16:189–194

    Google Scholar 

  24. Volm M, Sauerbrey A, Zintl F (1994) Dihydrofolate reductase and thymidylate synthase in childhood acute lymphoblastic leukemia. Anticancer Res (in press)

  25. Volm M, Sauerbrey A, Stammler G, Zintl F (1994) Detection of Fos, Jun and Ras in newly diagnosed childhood acute lymphoblastic leukemia by immunocytochemistry and PCR. Int J Oncol 4:1251–1256

    Google Scholar 

  26. Volm M, Sauerbrey A, Zintl F (1994) Prognostic significance of protein kinase C in newly diagnosed childhood acute lymphoblastic leukemia. Int J Oncol 4:363–368

    Google Scholar 

  27. Yamada H, Koizumi S (1991) Metallothionein induction in human peripheral blood lymphocytes by heavy metals. Chem Biol Interact 78:347–354

    PubMed  Google Scholar 

  28. Zintl F, Malke H, Reimann M, Domula M, Dörffel W, Eggers G, Exadaktylos P, Hilgenfeld E, Kotte W, Krause I, Kunert W, Mittler U, Möbius D, Reddemann H, Weinmann G, Weißbach G (1993) Results with randomized BFM-adopted studies for ALL therapy in childhood in east German counties. In: Büchner T, Schellong G, Hiddemann W, Urbanitz D, Ritter J (eds) Acute leukemias IV: prognostic factors. Springer, Berlin Heidelberg New York, pp 179–186

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sauerbrey, A., Zintl, F. & Volm, M. Expression of metallothionein in initial and relapsed childhood acute lymphoblastic leukemia. Ann Hematol 69, 111–115 (1994). https://doi.org/10.1007/BF01695690

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01695690

Key words

Navigation